Award
NIH Reporter #5P01HL171803-03
Core B - Microbial glycan microarray core
Recipient
Brigham and Women's Hospital
Award Amount
$304,853.00
Ceiling
$304,853.00
Awarded
September 09, 2026
Identifier
5P01HL171803-03
The National Heart, Lung, and Blood Institute awarded funding to Brigham and Women's Hospital for microbial glycan microarray tools to study naturally occurring anti-ABO(H) antibody responses and their clinical relevance.
Description
Funding supports validated microbial microarrays for high-throughput analysis of immune interactions with microbial glycans, including continued array generation and incorporation of newly identified blood-group-positive and blood-group-negative microbes and their glycans.